331 related articles for article (PubMed ID: 28007424)
1. Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease.
Atmanli A; Domian IJ
Trends Cell Biol; 2017 May; 27(5):352-364. PubMed ID: 28007424
[TBL] [Abstract][Full Text] [Related]
2. Human Pluripotent Stem Cell Mechanobiology: Manipulating the Biophysical Microenvironment for Regenerative Medicine and Tissue Engineering Applications.
Ireland RG; Simmons CA
Stem Cells; 2015 Nov; 33(11):3187-96. PubMed ID: 26189759
[TBL] [Abstract][Full Text] [Related]
3. On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.
Shao Y; Sang J; Fu J
Biomaterials; 2015 Jun; 52():26-43. PubMed ID: 25818411
[TBL] [Abstract][Full Text] [Related]
4. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.
Zhu R; Blazeski A; Poon E; Costa KD; Tung L; Boheler KR
Stem Cell Res Ther; 2014 Oct; 5(5):117. PubMed ID: 25688759
[TBL] [Abstract][Full Text] [Related]
5. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.
Hartman ME; Dai DF; Laflamme MA
Adv Drug Deliv Rev; 2016 Jan; 96():3-17. PubMed ID: 25980938
[TBL] [Abstract][Full Text] [Related]
6. Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease.
van Meer BJ; Tertoolen LG; Mummery CL
Stem Cells; 2016 Aug; 34(8):2008-15. PubMed ID: 27250776
[TBL] [Abstract][Full Text] [Related]
7. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.
Thavandiran N; Dubois N; Mikryukov A; Massé S; Beca B; Simmons CA; Deshpande VS; McGarry JP; Chen CS; Nanthakumar K; Keller GM; Radisic M; Zandstra PW
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):E4698-707. PubMed ID: 24255110
[TBL] [Abstract][Full Text] [Related]
8. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Fluorescent Reporters in Human Pluripotent Stem Cells: Contributions to Cardiac Differentiation and Their Applications in Cardiac Disease and Toxicity.
Den Hartogh SC; Passier R
Stem Cells; 2016 Jan; 34(1):13-26. PubMed ID: 26446349
[TBL] [Abstract][Full Text] [Related]
10. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
Duelen R; Sampaolesi M
EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
[TBL] [Abstract][Full Text] [Related]
11. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
[TBL] [Abstract][Full Text] [Related]
12. Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation.
Zhang M; Schulte JS; Heinick A; Piccini I; Rao J; Quaranta R; Zeuschner D; Malan D; Kim KP; Röpke A; Sasse P; Araúzo-Bravo M; Seebohm G; Schöler H; Fabritz L; Kirchhof P; Müller FU; Greber B
Stem Cells; 2015 May; 33(5):1456-69. PubMed ID: 25639979
[TBL] [Abstract][Full Text] [Related]
13. Stem cell niche: Dynamic neighbor of stem cells.
Singh A; Yadav CB; Tabassum N; Bajpeyee AK; Verma V
Eur J Cell Biol; 2019 Jun; 98(2-4):65-73. PubMed ID: 30563738
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
White MC; Pang L; Yang X
Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
[TBL] [Abstract][Full Text] [Related]
15. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.
Shaheen N; Shiti A; Gepstein L
Clin Pharmacol Ther; 2017 Aug; 102(2):203-208. PubMed ID: 28718902
[TBL] [Abstract][Full Text] [Related]
17. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
18. Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche.
Shao Y; Taniguchi K; Gurdziel K; Townshend RF; Xue X; Yong KMA; Sang J; Spence JR; Gumucio DL; Fu J
Nat Mater; 2017 Apr; 16(4):419-425. PubMed ID: 27941807
[TBL] [Abstract][Full Text] [Related]
19. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
Irion S; Nostro MC; Kattman SJ; Keller GM
Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
[TBL] [Abstract][Full Text] [Related]
20. Advances in microfluidic platforms for analyzing and regulating human pluripotent stem cells.
Qian T; Shusta EV; Palecek SP
Curr Opin Genet Dev; 2015 Oct; 34():54-60. PubMed ID: 26313850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
